A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.

The state Health Department has told hospitals to have guidelines in place to help them better recognize and treat conditions ...

If you are pregnant or nursing, talk with your health care professional about whether to enroll in pregnancy safety or ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25If approved, FILSPARI ...

AI-enabled ECG biological age (ECG-BA) improves disease risk classification beyond chronological age, enhancing early ...

Over 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, published in Science, from researchers at the Perelman School of Medicine at the ...

Multiple subcutaneous doses safe and well-tolerated >69% reduction in anti-VEGF intravitreal (IVT) treatment burden in study eyes >67% ...

In a groundbreaking theory, scientists at Arizona State University's Biodesign Institute propose a unifying explanation for the molecular chaos driving Alzheimer's disease.

The development of LivGels at Penn State offers a breakthrough in biomaterials, mimicking ECMs for improved tissue repair and ...

The American Cancer Society is calling on the Trump administration to restore access to comprehensive scientific data.